发布时间:
2017
-
12
-
29
点击次数:
0
Positions：
Vice President
Company：
Beijing Shenogen Biotech
个人简介：
Dr. Ye Graduated from Weizmann Institute Israel in 1998, followed by Post.Doc training in Harvard Medical School, was promoted as Assistant Professor in Brigham Women’s Hospital, affiliated Dana-Farber Cancer Center in 2008. He was awarded with several cancer Research grants including USA NIH Grants. Dr. Ye also actively served Science committee, Education Committee in USA Society of Integrative Oncology, and as Editorial reviewer of the high impact Journals, including Journal Clinical Oncology, Journal Clinical Investigation, Cancer Research, and contributed more than 40 original research papers and review articles, Dr. Ye has 5 USA patents; Since 2011, Dr. Ye shift his career gear to more clinical and cancer therapy, Joined Novartis as Senior Investigator, Heading Novartis China Biomarker group, lead the translational research, clinical trials and Biomarker outsourcing in GCLP compliance and industry standard. From 2014, Dr.Ye joined Shenogen Pharma Group, and now serve as Vice President, actively leading the Clinical Biomarker Translation in Immune-Modulation therapy in advanced HCC. .